People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aegle Therapeutics Corp | — | Biotechnology | Series A | $7.0M | $1.2M | 2025 |
Mikio Tanji at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mikio Tanji on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Ryan | 1 | 8 |
| Steve O'Hara | 1 | 6 |
| Elona Baum | 1 | 5 |
| Leon Moulder, Jr. | 1 | 3 |
| Leon Moulder | 1 | 3 |
| David Schimel | 1 | 2 |
| Scott Braunstein | 1 | 2 |
| Evangelos Badiavas | 1 | 1 |
| Robert Williamson, Jr. | 1 | 1 |
| Shelley Hartman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.